東京–(BUSINESS WIRE)–HOYA株式会社PENTAXライフケア事業部 新製品『PENTAX Medical 高周波ナイフ DN-Dシリーズ （愛称Splash M-Knife）』を販売開始
Category: Business
Kat Graham Set To Appear in Latest Foster Grant Advertising Campaign
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, is launching a nationwide consumer ad campaign for its Foster Grant® brand featuring its new spokesperson, popular actress and musician Kat Graham. Kat joins iconic actress and author Brooke Shields as the latest celebrity featured in the brand’s famous “Who’s that behind those Foster Grants®” campaign, which will feature ads on national network cable television as well as a digital component, slated
Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma
MUNICH–(BUSINESS WIRE)–EMA grants orphan drug designation for Isarna’s ISTH0036, a LNA-modified antisense oligonucleotide targeting TGF-β2, for the prevention of scarring post trabeculectomy in glaucoma.
Optikos CEO, Stephen D. Fantone Receives University of Rochester Distinguished Scholar Award
WAKEFIELD, Mass.–(BUSINESS WIRE)–Optikos CEO, Stephen D. Fantone, receives Rochester Distinguished Scholar Award at the University’s 2015 Doctoral Ceremony.
BioTime to Present at the Jefferies 2015 Global Healthcare Conference
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX) today announced that Chief Executive Officer Michael D. West, PhD will present at the Jefferies 2015 Global Healthcare Conference to be held in New York on June 1-4, 2015. Dr. West will pr…
Study: Comprehensive Eye Exams Can Help Re-Engage Patients into Care for Certain Chronic Conditions, with the Potential to Help Improve Health and Reduce Costs
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare study: comprehensive eye exams can help re-engage patients into care for certain chronic conditions, with the potential to help improve health and reduce costs.
pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida reports positive IOP Safety Data in Phase III Trial of Medidur for Posterior Uveitis
R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate Scho…
Modernizing Medicine Showcases EMA Gastroenterology EMR System at Annual Digestive Disease Week 2015
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), showcases EMA Gastroenterology at Digestive Disease Week Annual Conference in Washington, D.C.
Acucela Announces Publication of Pre-clinical Data for Emixustat Hydrochloride
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced the publication of pre-clinical data related to the company’s investigational drug candidate, emixustat hydrochloride (emixustat), in the scientific journal PLOS ONE. The published article, “Visual Cycle Modulation as an Approach Towa
Second Sight Reports First Quarter 2015 Financial Results
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three-month period ended March 31, 2015. Company Highlights Successfully implanted 19 Argus® II systems in the first quarter of 2015, the highest number for any quarter to date; Net revenue increased 159% to $1.7 millio
Technavio Publishes Global Capsule Endoscope Market Analysis & Forecast 2015-2019
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the global capsule endoscope market, which is expected to grow at a CAGR of 11% from 2015-2019.
Paragon BioTeck Enters Promotional Agreement to Expand Availability of ilast® Portfolio of Products
PORTLAND, Ore.–(BUSINESS WIRE)–Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, announced today that it has entered into a multi-year agreement with global healthcare supplier Perrigo Company plc to promote the ilast® range of products for eyelid hygiene in the United States. “The ilast® brand is an integral part of our portfolio of branded products,” said Patrick Witham, President and CEO of Paragon BioTeck, Inc. “By expanding our promotional efforts to incl
Glaukos Corporation Files Registration Statement for Proposed Initial Public Offering
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation, an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced tod…
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s Office of the Chief Scientist
ALAMEDA, Calif. & JERUSALEM–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has been awarded a grant for 2015 of 6.24 million shekels (approximately $1.61 million) from Israel’s Office of the Chief Scientist (OCS) to help finance the development of OpRegen®, a cell-based therapeutic product that consists of animal product-free retinal pigment epithelial (RPE) cells with high purity and potency. Cell Cure
Ophthotech Corporation to Present at the UBS Global Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the UBS Global Healthcare Conference in New York City on Monday, May 18, 2015.
Research and Markets: North American Ophthalmology Surgery Devices Market by Types, by End-Users – Forecast to 2019 Out Now
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/jjzjdp/north_american) has announced the addition of the “North American Ophthalmology Surgery Devices Market by Types, by End-users – Forecast to 2019” report to…
ISG Secures £4.5 Million Eye Hospital in Central London
LONDON–(BUSINESS WIRE)–ISG has commenced work on a £4.5 million project to create a state-of-the-art eye hospital in London’s renowned Marylebone medical district, for high-end ophthalmic specialist Optegra. The scheme involves the conversion of two period properties in Queen Anne Street into an advanced facility for the treatment of a comprehensive range of eye conditions. Retaining the attractive Edwardian and Victorian façades of the two buildings, ISG will rationalise and unify space and
FibroGen Announces First Quarter 2015 Financial Results
SAN FRANCISCO–(BUSINESS WIRE)–FibroGen, Inc. (NASDAQ:FGEN) (“FibroGen”), a research-based biopharmaceutical company, today reported financial results for the quarter ended March 31, 2015. “FibroGen and its partners, AstraZeneca and Astellas, continue to make excellent progress in the global development of roxadustat for the treatment of anemia in patients with chronic kidney disease,” said Thomas B. Neff, chief executive officer of FibroGen. “Patient enrollment in the seven Phase 3 studies re
Hoya Reports Fourth Quarter Results; Achieves Record Annual Sales and Profit
TOKYO–(BUSINESS WIRE)–HOYA Corporation (TOKYO: 7741) today announced financial results for the fourth quarter and full-year ended March 31, 2015. During the quarter, revenues increased by 10.6% to 127,440 million yen compared with the same period las…